36C25025Q0891.docx
DOCX document 16 KB Posted
- Solicitation number
- 36C25025Q0891
About this file
This is a Special Notice of Intent to Sole Source for PET MRI Radiopharmaceuticals issued by the Department of Veterans Affairs (VA) Network Contracting Office 10. The VA intends to award a sole source, firm-fixed price, 1-year purchase order to Sofie Co. for radiopharmaceutical supplies to be used at the John D. Dingell VA Medical Center in Detroit, MI. The contract will cover four specific radiopharmaceutical products: Cu-64 Dotatate (25 doses), F18 PSMA (70 doses), F18 Fluorodeoxyglucose (908 doses), and F18 Neuraceq (52 doses), with a performance period from October 1, 2025, through September 30, 2026.
The VA conducted a sources sought notice (36C25025Q0852) from August 18-22, 2025, which received responses from five contractors. After reviewing capabilities, the VA determined that Sofie Co. is the only vendor capable of providing all required radiopharmaceuticals. Interested parties may submit capability statements demonstrating competitive advantage to the Contracting Officer, Jeffrey Rozema, by 5:00 PM Eastern Time on September 2, 2025. The procurement falls under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing) with a business size standard of 1,300 employees.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Special Notice Special Notice
| SUBJECT* |
| PET MRI Radiopharmaceuticals - Notice of Intent to Sole Source |
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 49037 |
| SOLICITATION NUMBER* |
| 36C25025Q0891 |
| RESPONSE DATE/TIME/ZONE |
| 09-02-2025 5:00 PM EASTERN TIME, NEW YORK, USA |
| ARCHIVE |
| 60 DAYS AFTER THE RESPONSE DATE |
| RECOVERY ACT FUNDS |
| N |
| PRODUCT SERVICE CODE* |
| 6505 |
| NAICS CODE* |
| 325412 |
| CONTRACTING OFFICE ADDRESS |
| Department of Veteran Affairs |
Network Contracting Office 10 Battle Creek VA Medical Center 5500 Armstrong Rd.
Battle Creek MI 49037
POINT OF CONTACT*
Contracting Officer Jeffrey Rozema jeffrey.rozema@va.gov
ADDITIONAL INFORMATION
| AGENCY’S URL |
| https://www.va.gov |
| URL DESCRIPTION |
| Agency Homepage |
| AGENCY CONTACT’S EMAIL ADDRESS |
| jeffrey.rozema@va.gov |
| EMAIL DESCRIPTION |
| Contracting Officer |
DESCRIPTION
INTENT TO SOLE SOURCE
The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, intends to enter into a sole source procurement for PET MRI Radiopharmaceuticals for the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201. The Department of Veterans Affairs intends to award a sole source, firm-fixed price, 1-year purchase order to Sofie Co., 21000 Atlantic Blvd., Suite 730, Dulles, VA 20166. The associated North American Industry Classification System (NAICS) Code is 325412 – Pharmaceutical Preparation Manufacturing, and the Business Size Standard is 1,300 employees.
The contractor will furnish (including packaging, transportation, manifests, and reports) all PET radiopharmaceuticals listed below to the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201 for period of performance October 1, 2025, through September 30, 2026. These are PET radiopharmaceutical supplies used in Nuclear Medicine to perform exams on PET MRI patients.
| Product Name |
| UoM |
| Est. Annual Quantity |
| Cu-64 Dotatate (Detectnet) 3-5 mCi |
| Dose |
| 25 |
| F18 PSMA (Pylarify) 8-10 mCi |
| Dose |
| 70 |
| F18 Fluorodeoxyglucose (FDG) 8-10 mCi |
| Dose |
| 908 |
| F18 Neuraceq 8-10 mCi |
| Dose |
| 52 |
It is the Government’s belief that Sofie Co. is the only vendor capable of providing all of these specific radiopharmaceuticals for the Detroit VA. Sources sought notice 36C25025Q0852 was published on Contract Opportunities from August 18, 2025 through August 22, 2025. Responses were received from five contractors, including Sofie Co. Contractor capabilities were reviewed, and although the other contractors could provide some of the required products, Sofie Co. was the only contractor capable of providing all of these specific radiopharmaceuticals required by Detroit VA Nuclear Medicine.
This notice satisfies the requirement at FAR 5.201(b)(1) to publicize the proposed contract action. This notice of intent is not a request for competitive proposals or quotes. Interested parties may identify their interest and capability to respond to the requirement. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Interested persons may identify their interests and capability to respond to this requirement no later than 5:00 PM Eastern Time, Tuesday, September 2, 2025. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to meet the subject requirement. This information shall be provided at no cost or obligation to the Government.
Interest/capability statements shall be submitted to Jeffrey Rozema, Contracting Officer, via e-mail at jeffrey.rozema@va.gov. Telephone inquiries will not be accepted.
| *= Required Field |
| Special Notice |
Special Notice
File details come from the government source that posted it. Updated .